FeesSafety
Pluang+

Security flaw in Pennysia's Ethereum contract risks approved tokens; users urged to revoke permissions immediately

Market News
13 Nov 2026, 09:05 WIB
Tokenpost
View Source
Bearish
Security flaw in Pennysia's Ethereum contract risks approved tokens; users urged to revoke permissions immediately

Security firm 慢雾 warned that Pennysia's Settlement contract on Ethereum was exploited due to a flaw allowing arbitrary external calls. This flaw enabled attackers to transfer tokens that users had approved for the contract but not yet used, putting those assets at risk. Users who have ever approved tokens for this contract are advised to revoke permissions immediately to prevent further losses. The issue highlights the risks of token approvals in smart contracts when unused tokens remain authorized.

The story about the Pennysia Ethereum Settlement contract exploit is presented with Pluang's market data as of Nov 13, 2026 13:51 WIB. For readers following major cryptocurrencies, here is Pluang's market snapshot: out of 50 major cryptocurrencies, 12 rose and 37 fell today. Notable movers include UNI at Rp105.577 with a -5.39% change, ETH at Rp35.176.838 with a -5.08% change, and AAVE at Rp2.027.233 with a -4.40% change. The most notable figure is the 83% buy order activity for Ethereum on Pluang.

More News

Eramet launches €500M share capital increase with preferential subscription rights to reduce debt.

Eramet launches €500M share capital increase with preferential subscription rights to reduce debt.

Eramet announced a €500 million share capital increase through a rights issue, offering 6 new shares for every 5 existing shares at €14.49 each. The proceeds will be used to reduce the company's debt and strengthen its balance sheet as part of a prev...

Company Fundamentals
Neutral
14 minutes ago
PAS-004 shows strong reductions in neurofibroma size with good safety, advancing to Phase 2 trials after FDA clearance.

PAS-004 shows strong reductions in neurofibroma size with good safety, advancing to Phase 2 trials after FDA clearance.

Pasithea Therapeutics announced positive Phase 1/1b results for PAS-004, showing significant reductions in cutaneous neurofibromas (cNF) size by up to 71% with continued treatment and early activity in plexiform neurofibromas (PN). The drug demonstra...

Company Fundamentals
Bullish
14 minutes ago
Shandong-South Korea Economic Conference opens with 23 new cooperation projects signed in Yantai.

Shandong-South Korea Economic Conference opens with 23 new cooperation projects signed in Yantai.

The 9th Shandong-South Korea Economic and Trade Cooperation Conference and Yantai South Korea Week began on November 6 in Yantai, Shandong Province, highlighting strong economic ties between Shandong and South Korea. Over 150 enterprises participated...

Bullish
1 hour ago
Ethereum wallet sells 16,700 ETH from 2015 ICO, losing $6.97M on recent trades

Ethereum wallet sells 16,700 ETH from 2015 ICO, losing $6.97M on recent trades

An Ethereum wallet that originally acquired 38,800 ETH during the 2015 ICO sold 16,700 ETH in one transaction worth over $32.3 million. This sale represented about 43% of its original ICO allocation, which was purchased at just 31 cents per ETH. Howe...

Market News
Bearish
5 hours ago
Bitcoin dominance at 61% will determine if altcoins can gain ground after mixed recent gains.

Bitcoin dominance at 61% will determine if altcoins can gain ground after mixed recent gains.

Bitcoin's market dominance, currently around 61%, is crucial in deciding the near-term performance of altcoins. While Bitcoin gained 16.6% over the past 90 days, only 31 altcoins outperformed it, with a few like Bitway and Quant showing strong gains....

Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App